Brandes Investment Partners’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-15,810
Closed -$223K 163
2014
Q3
$223K Sell
15,810
-149,480
-90% -$2.88M ﹤0.01% 137
2014
Q2
$2.77M Buy
165,290
+165
+0.1% +$2.34K 0.03% 98
2014
Q1
$2.46M Sell
165,125
-50,515
-23% -$777K 0.03% 106
2013
Q4
$3.15M Sell
215,640
-13,525
-6% -$218K 0.04% 103
2013
Q3
$3.94M Buy
229,165
+285
+0.1% +$4.23K 0.05% 103
2013
Q2
$2.66M Buy
+228,880
New +$2.62M 0.03% 118

Other funds holding AMED

Brandes Investment Partners's AMED Position: Q4 2014 in Review

Brandes Investment Partners sold out of Amedisys (AMED) in Q4 2014, closing a stake of 15,810 shares — an estimated $223K sold.

Brandes Investment Partners first reported a position in AMED in Q2 2013 and held it in 6 quarters. The position peaked at $3.94M in Q3 2013. 137 funds tracked by Wall St. Rank hold AMED as of Q4 2014.

  • Brandes Investment Partners reported no remaining Amedisys position as of Q4 2014 after selling out during the quarter.
  • Brandes Investment Partners sold 15,810 Amedisys shares in Q4 2014, an estimated $223K.
  • Brandes Investment Partners first reported a position in Amedisys in Q2 2013 and held it in 6 quarters.
  • Brandes Investment Partners's Amedisys position peaked at $3.94M in Q3 2013.
  • 137 funds tracked by Wall St. Rank held Amedisys as of Q4 2014.

Based on Brandes Investment Partners's 13F filing for Q4 2014, filed 10 Feb 2015.